nitrosobis(2-oxopropyl)amine has been researched along with Hyperlipidemias in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujii, G; Imai, T; Ishigamori, R; Mutoh, M; Takahashi, M | 1 |
| Mutoh, M; Niho, N; Sakano, K; Sato, H; Sugimura, T; Takahashi, M; Takeuchi, Y; Wakabayashi, K; Yamamoto, M | 1 |
1 review(s) available for nitrosobis(2-oxopropyl)amine and Hyperlipidemias
| Article | Year |
|---|---|
Involvement of inflammatory factors in pancreatic carcinogenesis and preventive effects of anti-inflammatory agents.
Topics: Adipokines; Animals; Anti-Inflammatory Agents; Carcinogens; Cricetinae; Cyclooxygenase 2; Diabetes Mellitus, Type 2; Gene Expression Regulation, Neoplastic; Humans; Hyperlipidemias; Inflammation Mediators; Neoplasm Proteins; Neoplasms, Experimental; Nitric Oxide Synthase Type II; Nitrosamines; Obesity; Pancreatic Neoplasms; Pancreatitis; Risk Factors | 2013 |
1 other study(ies) available for nitrosobis(2-oxopropyl)amine and Hyperlipidemias
| Article | Year |
|---|---|
Suppression of N-nitrosobis(2-oxopropyl)amine-induced pancreatic carcinogenesis in hamsters by pioglitazone, a ligand of peroxisome proliferator-activated receptor gamma.
Topics: Animals; Antineoplastic Agents; Carcinogens; Cricetinae; Female; Hyperlipidemias; Ligands; Lipoprotein Lipase; Mesocricetus; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nitrosamines; Pancreatic Neoplasms; Pioglitazone; PPAR gamma; Rats; Rats, Inbred F344; Rats, Wistar; Thiazolidinediones | 2007 |